Characterization of TEM1/endosialin in human and murine brain tumors.
about
Safety of targeting tumor endothelial cell antigensCancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmA differential role for CD248 (Endosialin) in PDGF-mediated skeletal muscle angiogenesisDevelopment of 124I immuno-PET targeting tumor vascular TEM1/endosialin.CD248 facilitates tumor growth via its cytoplasmic domain.Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications.Molecular alterations in glioblastoma: potential targets for immunotherapy.Characteristics of human Ewing/PNET sarcoma models.TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cellsSpecial AT-rich sequence binding protein 1 expression correlates with response to preoperative radiotherapy and clinical outcome in rectal cancer.Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature.Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer.Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.Isolation of CD248-expressing stromal vascular fraction for targeted improvement of wound healing.CD248 and its cytoplasmic domain: a therapeutic target for arthritis.CD93 promotes integrin-β1 activation and fibronectin fibrillogenesis during tumor angiogenesis.
P2860
Q26748863-D67D4EA4-3258-4B34-95F1-889811CE8AF1Q26778150-2C0D751A-3335-4AE8-8224-7AC06FE2700DQ27026630-528F76B0-C9AA-4D54-A392-75F224FB95FCQ27348518-305A8410-BAFD-49B2-A0E5-8AA792FD11AEQ33872675-5445DE10-3140-4F7D-AED1-C32CA4681219Q33891662-67F90E3A-FAEF-46C6-B34B-CF6DF7066837Q34481202-28FF5FFC-1CAA-47BE-B9DB-605F0527DB50Q34870511-2012B457-FD60-486A-B5B2-2B3B5A53F424Q35008659-A2C4A2B3-71C5-46CA-9672-C868E985D93DQ35098665-C3E01795-7594-4B5E-90E4-41FF4F3DE991Q36843783-7147C982-F51E-41F0-A703-486CC5AE4054Q37679962-2CB12AF4-4693-45EF-A73A-68118512D98EQ37721844-9371424F-2BF5-4567-AEEE-A203A205AFB5Q38565385-FA5D9DC6-AE40-4758-BAEE-CF8007475EE1Q46007284-93C1DF1C-9C87-4710-9703-1A8C0140BC19Q49092320-302C4C19-50BA-406E-AC5F-96DA50EBA3DFQ54979076-EFA4E755-B280-44E4-AF1B-4FE4C96B5737
P2860
Characterization of TEM1/endosialin in human and murine brain tumors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Characterization of TEM1/endosialin in human and murine brain tumors.
@ast
Characterization of TEM1/endosialin in human and murine brain tumors.
@en
type
label
Characterization of TEM1/endosialin in human and murine brain tumors.
@ast
Characterization of TEM1/endosialin in human and murine brain tumors.
@en
prefLabel
Characterization of TEM1/endosialin in human and murine brain tumors.
@ast
Characterization of TEM1/endosialin in human and murine brain tumors.
@en
P2093
P2860
P356
P1433
P1476
Characterization of TEM1/endosialin in human and murine brain tumors.
@en
P2093
Bethany N Winans
Betty M Tyler
David L Huso
Eleanor B Carson-Walter
Hannu Haapasalo
Kevin A Walter
Mahlon D Johnson
Melissa C Whiteman
Sally Jarvela
P2860
P2888
P356
10.1186/1471-2407-9-417
P407
P577
2009-11-30T00:00:00Z
P5875
P6179
1053378780